Chad K. Porter

4.8k total citations
128 papers, 3.0k citations indexed

About

Chad K. Porter is a scholar working on Infectious Diseases, Endocrinology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chad K. Porter has authored 128 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Infectious Diseases, 44 papers in Endocrinology and 23 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chad K. Porter's work include Viral gastroenteritis research and epidemiology (84 papers), Escherichia coli research studies (41 papers) and Clostridium difficile and Clostridium perfringens research (31 papers). Chad K. Porter is often cited by papers focused on Viral gastroenteritis research and epidemiology (84 papers), Escherichia coli research studies (41 papers) and Clostridium difficile and Clostridium perfringens research (31 papers). Chad K. Porter collaborates with scholars based in United States, Peru and Egypt. Chad K. Porter's co-authors include Mark S. Riddle, David R. Tribble, Stephen J. Savarino, Ramiro L. Gutiérrez, Sandra D. Isidean, Brooks D. Cash, Joseph A. Murray, Robert Gormley, Shahida Baqar and Patricia Guerry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Gastroenterology.

In The Last Decade

Chad K. Porter

122 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chad K. Porter United States	32	1.8k	1.1k	750	408	389	128	3.0k
Zhi‐Dong Jiang United States	27	1.2k 0.6×	562 0.5×	295 0.4×	183 0.4×	463 1.2×	75	2.4k
Robert W. Frenck United States	40	1.9k 1.0×	674 0.6×	452 0.6×	168 0.4×	326 0.8×	116	4.7k
Linda Chui Canada	31	1.7k 0.9×	746 0.7×	731 1.0×	48 0.1×	511 1.3×	167	3.2k
Amee R. Manges Canada	33	1.5k 0.8×	1.8k 1.5×	961 1.3×	432 1.1×	1.7k 4.3×	73	5.3k
Pradip Kumar Bardhan Bangladesh	31	803 0.4×	554 0.5×	222 0.3×	274 0.7×	217 0.6×	98	2.7k
Anne Collignon France	40	3.0k 1.7×	354 0.3×	322 0.4×	256 0.6×	1.2k 3.0×	119	4.1k
Rosa Bartolomé Spain	25	927 0.5×	233 0.2×	322 0.4×	121 0.3×	200 0.5×	65	2.0k
James P. Nataro United States	37	2.3k 1.3×	2.2k 1.9×	928 1.2×	41 0.1×	779 2.0×	81	4.7k
David B. Huang United States	31	1.5k 0.8×	616 0.5×	356 0.5×	32 0.1×	529 1.4×	129	3.3k
Ingegerd Adlerberth Sweden	35	943 0.5×	606 0.5×	986 1.3×	283 0.7×	2.0k 5.2×	84	4.5k

Countries citing papers authored by Chad K. Porter

Since Specialization

Citations

This map shows the geographic impact of Chad K. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad K. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad K. Porter more than expected).

Fields of papers citing papers by Chad K. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad K. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad K. Porter. The network helps show where Chad K. Porter may publish in the future.

Co-authorship network of co-authors of Chad K. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Chad K. Porter. A scholar is included among the top collaborators of Chad K. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad K. Porter. Chad K. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lopman, Benjamin A., et al.. (2025). The Impact of Coronavirus Disease 2019 Nonpharmaceutical Interventions on Incidence of Acute Gastroenteritis and Acute Respiratory Infections Among US Military and Dependents. The Journal of Infectious Diseases. 231(6). e1075–e1079. 1 indexed citations

Liechty, Zachary, Sandra D. Isidean, Akamol E. Suvarnapunya, et al.. (2025). Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model. mSphere. 10(4). e0090624–e0090624.

Clements, John D., et al.. (2025). Protective antibodies against enterotoxigenic Escherichia coli are generated from heat-labile toxoid vaccination and exhibit subject- and vaccine-specific diversity. Medical Microbiology and Immunology. 214(1). 10–10. 1 indexed citations

Porter, Chad K., Charmagne Beckett, Lindsey White, et al.. (2024). Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study. The Lancet Regional Health - Americas. 39. 100909–100909. 2 indexed citations

Maier, Nicole, Shannon Grahek, Jane L. Halpern, et al.. (2023). Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score. Microorganisms. 11(10). 2414–2414. 5 indexed citations

Duplessis, Christopher, Kristen A. Clarkson, K. Ross Turbyfill, et al.. (2023). GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers. Vaccine. 41(42). 6261–6271. 3 indexed citations

Sedegah, Martha, Chad K. Porter, Michael R. Hollingdale, et al.. (2022). CHARM: COVID-19 Health Action Response for Marines–Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test. PLoS ONE. 17(4). e0266691–e0266691.

Loza, Matthew J., Sunil Nagpal, Suzanne Cole, et al.. (2022). Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel. Arthritis & Rheumatology. 74(11). 1766–1775. 4 indexed citations

Mantua, Janna, Ramiro L. Gutiérrez, Sandra D. Isidean, et al.. (2022). Sleep duration prior to an enterotoxigenic Escherichia coli challenge predicts diarrhea severity during infection. Sleep Medicine. 100. 404–409.

10.

Gutiérrez, Ramiro L., Milton Maciel, S. Poole, et al.. (2021). Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli. Vaccine. 39(39). 5548–5556. 27 indexed citations

11.

Clarkson, Kristen A., Chad K. Porter, Kawsar R. Talaat, et al.. (2021). Shigella -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei. mSphere. 6(4). e0012221–e0012221. 11 indexed citations

12.

Clarkson, Kristen A., Chad K. Porter, Kawsar R. Talaat, et al.. (2021). Shigella-Controlled Human Infection Models: Current and Future Perspectives. Current topics in microbiology and immunology. 445. 257–313. 3 indexed citations

13.

Pogreba-Brown, Kristen, Ama Owusu-Dommey, Michael C. Bazaco, et al.. (2021). Enteric Pathogens and Reactive Arthritis: Systematic Review and Meta-Analyses of Pathogen-Associated Reactive Arthritis. Foodborne Pathogens and Disease. 18(9). 627–639. 13 indexed citations

14.

Frenck, Robert W., Michelle Dickey, Akamol E. Suvarnapunya, et al.. (2020). Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G. mSphere. 5(5). 15 indexed citations

15.

Clarkson, Kristen A., Robert W. Frenck, Michelle Dickey, et al.. (2020). Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G. mSphere. 5(5). 29 indexed citations

16.

Porter, Chad K., Mark S. Riddle, Renée M. Laird, et al.. (2020). Cohort profile of a US military population for evaluating pre-disease and disease serological biomarkers in rheumatoid and reactive arthritis: Rationale, organization, design, and baseline characteristics. Contemporary Clinical Trials Communications. 17. 100522–100522. 7 indexed citations

17.

Talaat, Kawsar R., A. Louis Bourgeois, Robert W. Frenck, et al.. (2019). Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies. Clinical Infectious Diseases. 69(Supplement_8). S580–S590. 26 indexed citations

18.

Maue, Alexander C., Krystle L. Mohawk, David K. Giles, et al.. (2013). The Polysaccharide Capsule of <i>Campylobacter jejuni</i> Modulates the\nHost Immune Response. Insecta mundi. 61 indexed citations

19.

McKenzie, R., Chad K. Porter, Joyce A. Cantrell, et al.. (2011). Volunteer Challenge With Enterotoxigenic Escherichia coli That Express Intestinal Colonization Factor Fimbriae CS17 and CS19. The Journal of Infectious Diseases. 204(1). 60–64. 19 indexed citations

20.

Porter, Chad K., David R. Tribble, Pablo A. Aliaga, Heather Halvorson, & Mark S. Riddle. (2008). Infectious Gastroenteritis and Risk of Developing Inflammatory Bowel Disease. Gastroenterology. 135(3). 781–786. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact